News from the web:
Read today’s story about a woman, diagnosed with Alzheimer’s disease already at age 46 and how she, in the past 11 years, has adapted her life and prepared for what is coming. She knows there is no cure but she does everything to prepare for excellent care.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
Bearing in mind the note yesterday about the frequent hypes about wonder drugs to reverse Alzheimer’s disease, still we bring you today the news about a epilepsy drug that shows some promise in trails with animals. Lots of ifs and buts though as the Alzheimer is not the Human form but genetically modified and mice are not humans but still, we need some hope and continue to encourage research into novel ways to cure this terrible disease.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
Interesting viewpoint here where Howard Gleckman makes a point about the fact that we continue to be bombarded with the ever brilliant cure for Alzheimer’s disease while we should know by now that there is no such thing as a quick fix and maybe we should all start putting more emphasis on care instead of continuing to hope and pour money in the illusive cure.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
With the disappointing news about the outcome of various clinical trails this month, the investors are looking how this shapes the trading environment in Alzheimer related companies for them. Follow the link to find a trading review that also, in reviewing the options for trading shows the current state of the trails and drug development for Alzheimer’s
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
In an experiment with rats, stem cells were injected in their brains and seemed to restore memory functions. This is not the first experiment with stem cells but it is the first where the treatment was shown to have a positive effect on memory functions. Lots more research will be necessary to get this treatment to be accepted as a way to treat Alzheimer’s but it is yet another option we will be watching.
Read all about it HERE
visit us at AlzheimerHeadlines.com
News from the web:
University Feinberg School of Medicine have developed a new “one-size-fits-all” therapy drug that could potentially treat Alzheimer’s, Parkinson’s disease, multiple sclerosis and traumatic brain injury
The drug’s trick lies in reducing a particular type of inflammation in the brain known as neuroinflammation. This brain response has become increasingly considered a common denominator for many neurological disorders, as well as playing a major role in brain injuries. To decrease inflammation, the drug developed at Northwestern binds to and decreases a molecule known as cytokine, which is released in large quantities during the neuroinflammatory response.
Read all about it HERE
visit us at AlzheimerHeadlines.com